Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRE: Carfilzomib, Lenalidomide, and Dexamethasone vs Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma
NCT01080391Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2010
- Primary completion
- Jun 2014
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 20
01
Overview
A Phase 3 trial of carfilzomib in multiple myeloma (MM), sponsored by Amgen. Started Jul 2010; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01080391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01080391.